Embecta: Excellent Turnaround Prospect In Defensive Medical Products (NASDAQ:EMBC)
· seekingalpha.com
Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.
Nationally ranked stock picker for 30+ years. Victory Formation and Bottom Fishing Club quant-sort pioneer.....Paul Franke is a private investor and speculator ...